Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2014

Open Access 01-05-2014 | Poster presentation

Psychological features in lower risk melanoma: an analysis on 204 patients

Authors: Ribero Simone, Bassino Stefania, Castelli Lorys, Grassi Marcella, Caliendo Virginia, Lauro Danilo, Balagna Elena Maira, Giaretti Marta, Leombruni Paolo, Torta Riccardo, Macripo Giuseppe

Published in: Journal of Translational Medicine | Special Issue 1/2014

Login to get access

Excerpt

To describe psychological status in melanoma patients in a high risk distress moment: the follow up consultation. Secondly to know if there are any difference in distress and in other psychological variables between melanoma patients at stage Ib-II vs 0-Ia AJCC (American Joint Committed Cancer) and to correlate these with clinical variables. …
Metadata
Title
Psychological features in lower risk melanoma: an analysis on 204 patients
Authors
Ribero Simone
Bassino Stefania
Castelli Lorys
Grassi Marcella
Caliendo Virginia
Lauro Danilo
Balagna Elena Maira
Giaretti Marta
Leombruni Paolo
Torta Riccardo
Macripo Giuseppe
Publication date
01-05-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue Special Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-12-S1-P4

Other articles of this Special Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue

Oral presentation

Harnessing host innate immunity may combat acquired resistance to BRAFi

Oral presentation

Regulated intratumoral expression of IL-12 as a basis for combination therapy in melanoma

Poster presentation

A novel approach to target metastases of melanoma cells in an organ-selective manner

Poster presentation

Long-term response after electrochemotherapy in patients with relapsed or refractory cutaneous melanoma

Oral presentation

Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma

Oral presentation

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits